Low-dose methylprednisolone treatment in critically ill patients with severe community-acquired pneumonia.

Gianfranco Umberto MeduriMei-Chiung ShihLisa BridgesThomas J MartinAli El-SolhNitin SeamAnne Davis-KarimReba UmbergerAntonio AnzuetoPeruvemba SriramCharlie LanMarcos I RestrepoJuan J GuardiolaTeresa BuckDavid P JohnsonAnthony SuffrediniW Andrew BellJulia LinLan ZhaoLauren UyedaLori NielsenGrant D Huangnull null

Published in: Intensive care medicine (2022)

In patients with severe CAP, prolonged low-dose methylprednisolone treatment did not significantly reduce 60-day mortality. Treatment was not associated with increased complications.

Keyphrases

low dose
high dose
cardiovascular disease
risk factors
early onset
coronary artery disease
combination therapy
replacement therapy
smoking cessation